NEW YORK, Nov. 23 (GenomeWeb News) - Shares in Nanogen were up 5.24 percent at $4.02 in heavy mid-afternoon trading as investors cheered a new patent the company won in the United States for DNA microarrays.

 

The stock briefly climbed to $4.20 earlier in the day, and trading volume hovered around 1.4 million shares, almost two-and-a-half times their average volume.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

CNN reports that researchers have tied a new variant to opioid addiction risk.

Organoids derived from patients' tumors may help determine what chemotherapy treatment patients would benefit from, according to New Scientist.

An initiative from GenomeAsia 100K hopes to increase the number of South Asians in genetic research, according to NBC News.

In Science this week: genomic analysis of ancient and modern horses indicates population turnover, and more.